SCHEMBL26046288

SCHEMBL26046288

C=C(N)/C=C(\C)C1CCCC1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 2/20 0.37
CTSK P43235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14613115 0.91
SCHEMBL10891915 0.79 CES2 (0.35) CTSK
SCHEMBL1269840 0.76 ALDH1A1 (0.30)
SCHEMBL1269842 0.76 ALDH1A1 (0.30)
SCHEMBL8032516 0.76 CTSK (0.44) NOS2CTSK
SCHEMBL8032521 0.76 CTSK (0.44) NOS2CTSK
SCHEMBL8034602 0.76 CES2 (0.42) NOS2CTSK
SCHEMBL8034597 0.76 CES2 (0.42) NOS2CTSK
SCHEMBL18517622 0.76
SCHEMBL9609535 0.74 CES2 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023164612-A9 MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN NALO THERAPEUTICS (US) 2024-05-30 WO disclosed
WO-2023163712-A1 MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN NALO THERAPEUTICS (US) 2023-08-31 WO disclosed
WO-2023164612-A1 MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN NALO THERAPEUTICS (US) 2023-08-31 WO disclosed
WO-2023164611-A1 MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN NALO THERAPEUTICS (US) 2023-08-31 WO disclosed